Global Prenatal Cell-Free DNA Screening Supply, Demand and Key Producers, 2023-2029

May 2024 | 110 pages | ID: G43C65C8E087EN
GlobalInfoResearch

Abstracts

The global Prenatal Cell-Free DNA Screening market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Prenatal Cell-Free DNA Screening demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Prenatal Cell-Free DNA Screening, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Prenatal Cell-Free DNA Screening that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Prenatal Cell-Free DNA Screening total market, 2018-2029, (USD Million)

Global Prenatal Cell-Free DNA Screening total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Prenatal Cell-Free DNA Screening total market, key domestic companies and share, (USD Million)

Global Prenatal Cell-Free DNA Screening revenue by player and market share 2018-2023, (USD Million)

Global Prenatal Cell-Free DNA Screening total market by Type, CAGR, 2018-2029, (USD Million)

Global Prenatal Cell-Free DNA Screening total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Prenatal Cell-Free DNA Screening market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Yourgene Health, Illumina Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc and BGI, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Prenatal Cell-Free DNA Screening market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Prenatal Cell-Free DNA Screening Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Prenatal Cell-Free DNA Screening Market, Segmentation by Type

• Combined First Trimester Screening
• Second Trimester Maternal Serum Screening

Global Prenatal Cell-Free DNA Screening Market, Segmentation by Application

• Diagnostic Laboratories
• Hospitals

Companies Profiled:

• Yourgene Health
• Illumina Inc
• Agilent Technologies Inc
• Thermo Fisher Scientific Inc
• Hoffmann-La Roche Ltd
• Laboratory Corporation of America Holdings
• GE Healthcare
• PerkinElmer Inc
• BGI
• Natera Inc

Key Questions Answered

1. How big is the global Prenatal Cell-Free DNA Screening market?

2. What is the demand of the global Prenatal Cell-Free DNA Screening market?

3. What is the year over year growth of the global Prenatal Cell-Free DNA Screening market?

4. What is the total value of the global Prenatal Cell-Free DNA Screening market?

5. Who are the major players in the global Prenatal Cell-Free DNA Screening market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Prenatal Cell-Free DNA Screening Introduction
1.2 World Prenatal Cell-Free DNA Screening Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Prenatal Cell-Free DNA Screening Total Market by Region (by Headquarter Location)
  1.3.1 World Prenatal Cell-Free DNA Screening Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Prenatal Cell-Free DNA Screening Market Size (2018-2029)
  1.3.3 China Prenatal Cell-Free DNA Screening Market Size (2018-2029)
  1.3.4 Europe Prenatal Cell-Free DNA Screening Market Size (2018-2029)
  1.3.5 Japan Prenatal Cell-Free DNA Screening Market Size (2018-2029)
  1.3.6 South Korea Prenatal Cell-Free DNA Screening Market Size (2018-2029)
  1.3.7 ASEAN Prenatal Cell-Free DNA Screening Market Size (2018-2029)
  1.3.8 India Prenatal Cell-Free DNA Screening Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Prenatal Cell-Free DNA Screening Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Prenatal Cell-Free DNA Screening Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Prenatal Cell-Free DNA Screening Consumption Value (2018-2029)
2.2 World Prenatal Cell-Free DNA Screening Consumption Value by Region
  2.2.1 World Prenatal Cell-Free DNA Screening Consumption Value by Region (2018-2023)
  2.2.2 World Prenatal Cell-Free DNA Screening Consumption Value Forecast by Region (2024-2029)
2.3 United States Prenatal Cell-Free DNA Screening Consumption Value (2018-2029)
2.4 China Prenatal Cell-Free DNA Screening Consumption Value (2018-2029)
2.5 Europe Prenatal Cell-Free DNA Screening Consumption Value (2018-2029)
2.6 Japan Prenatal Cell-Free DNA Screening Consumption Value (2018-2029)
2.7 South Korea Prenatal Cell-Free DNA Screening Consumption Value (2018-2029)
2.8 ASEAN Prenatal Cell-Free DNA Screening Consumption Value (2018-2029)
2.9 India Prenatal Cell-Free DNA Screening Consumption Value (2018-2029)

3 WORLD PRENATAL CELL-FREE DNA SCREENING COMPANIES COMPETITIVE ANALYSIS

3.1 World Prenatal Cell-Free DNA Screening Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Prenatal Cell-Free DNA Screening Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Prenatal Cell-Free DNA Screening in 2022
  3.2.3 Global Concentration Ratios (CR8) for Prenatal Cell-Free DNA Screening in 2022
3.3 Prenatal Cell-Free DNA Screening Company Evaluation Quadrant
3.4 Prenatal Cell-Free DNA Screening Market: Overall Company Footprint Analysis
  3.4.1 Prenatal Cell-Free DNA Screening Market: Region Footprint
  3.4.2 Prenatal Cell-Free DNA Screening Market: Company Product Type Footprint
  3.4.3 Prenatal Cell-Free DNA Screening Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Prenatal Cell-Free DNA Screening Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Prenatal Cell-Free DNA Screening Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Prenatal Cell-Free DNA Screening Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Prenatal Cell-Free DNA Screening Consumption Value Comparison
  4.2.1 United States VS China: Prenatal Cell-Free DNA Screening Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Prenatal Cell-Free DNA Screening Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Prenatal Cell-Free DNA Screening Companies and Market Share, 2018-2023
  4.3.1 United States Based Prenatal Cell-Free DNA Screening Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Prenatal Cell-Free DNA Screening Revenue, (2018-2023)
4.4 China Based Companies Prenatal Cell-Free DNA Screening Revenue and Market Share, 2018-2023
  4.4.1 China Based Prenatal Cell-Free DNA Screening Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Prenatal Cell-Free DNA Screening Revenue, (2018-2023)
4.5 Rest of World Based Prenatal Cell-Free DNA Screening Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Prenatal Cell-Free DNA Screening Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Prenatal Cell-Free DNA Screening Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Prenatal Cell-Free DNA Screening Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Combined First Trimester Screening
  5.2.2 Second Trimester Maternal Serum Screening
5.3 Market Segment by Type
  5.3.1 World Prenatal Cell-Free DNA Screening Market Size by Type (2018-2023)
  5.3.2 World Prenatal Cell-Free DNA Screening Market Size by Type (2024-2029)
  5.3.3 World Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Prenatal Cell-Free DNA Screening Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Diagnostic Laboratories
  6.2.2 Hospitals
6.3 Market Segment by Application
  6.3.1 World Prenatal Cell-Free DNA Screening Market Size by Application (2018-2023)
  6.3.2 World Prenatal Cell-Free DNA Screening Market Size by Application (2024-2029)
  6.3.3 World Prenatal Cell-Free DNA Screening Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Yourgene Health
  7.1.1 Yourgene Health Details
  7.1.2 Yourgene Health Major Business
  7.1.3 Yourgene Health Prenatal Cell-Free DNA Screening Product and Services
  7.1.4 Yourgene Health Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Yourgene Health Recent Developments/Updates
  7.1.6 Yourgene Health Competitive Strengths & Weaknesses
7.2 Illumina Inc
  7.2.1 Illumina Inc Details
  7.2.2 Illumina Inc Major Business
  7.2.3 Illumina Inc Prenatal Cell-Free DNA Screening Product and Services
  7.2.4 Illumina Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Illumina Inc Recent Developments/Updates
  7.2.6 Illumina Inc Competitive Strengths & Weaknesses
7.3 Agilent Technologies Inc
  7.3.1 Agilent Technologies Inc Details
  7.3.2 Agilent Technologies Inc Major Business
  7.3.3 Agilent Technologies Inc Prenatal Cell-Free DNA Screening Product and Services
  7.3.4 Agilent Technologies Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Agilent Technologies Inc Recent Developments/Updates
  7.3.6 Agilent Technologies Inc Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific Inc
  7.4.1 Thermo Fisher Scientific Inc Details
  7.4.2 Thermo Fisher Scientific Inc Major Business
  7.4.3 Thermo Fisher Scientific Inc Prenatal Cell-Free DNA Screening Product and Services
  7.4.4 Thermo Fisher Scientific Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Thermo Fisher Scientific Inc Recent Developments/Updates
  7.4.6 Thermo Fisher Scientific Inc Competitive Strengths & Weaknesses
7.5 Hoffmann-La Roche Ltd
  7.5.1 Hoffmann-La Roche Ltd Details
  7.5.2 Hoffmann-La Roche Ltd Major Business
  7.5.3 Hoffmann-La Roche Ltd Prenatal Cell-Free DNA Screening Product and Services
  7.5.4 Hoffmann-La Roche Ltd Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Hoffmann-La Roche Ltd Recent Developments/Updates
  7.5.6 Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.6 Laboratory Corporation of America Holdings
  7.6.1 Laboratory Corporation of America Holdings Details
  7.6.2 Laboratory Corporation of America Holdings Major Business
  7.6.3 Laboratory Corporation of America Holdings Prenatal Cell-Free DNA Screening Product and Services
  7.6.4 Laboratory Corporation of America Holdings Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Laboratory Corporation of America Holdings Recent Developments/Updates
  7.6.6 Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
7.7 GE Healthcare
  7.7.1 GE Healthcare Details
  7.7.2 GE Healthcare Major Business
  7.7.3 GE Healthcare Prenatal Cell-Free DNA Screening Product and Services
  7.7.4 GE Healthcare Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 GE Healthcare Recent Developments/Updates
  7.7.6 GE Healthcare Competitive Strengths & Weaknesses
7.8 PerkinElmer Inc
  7.8.1 PerkinElmer Inc Details
  7.8.2 PerkinElmer Inc Major Business
  7.8.3 PerkinElmer Inc Prenatal Cell-Free DNA Screening Product and Services
  7.8.4 PerkinElmer Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 PerkinElmer Inc Recent Developments/Updates
  7.8.6 PerkinElmer Inc Competitive Strengths & Weaknesses
7.9 BGI
  7.9.1 BGI Details
  7.9.2 BGI Major Business
  7.9.3 BGI Prenatal Cell-Free DNA Screening Product and Services
  7.9.4 BGI Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 BGI Recent Developments/Updates
  7.9.6 BGI Competitive Strengths & Weaknesses
7.10 Natera Inc
  7.10.1 Natera Inc Details
  7.10.2 Natera Inc Major Business
  7.10.3 Natera Inc Prenatal Cell-Free DNA Screening Product and Services
  7.10.4 Natera Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 Natera Inc Recent Developments/Updates
  7.10.6 Natera Inc Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Prenatal Cell-Free DNA Screening Industry Chain
8.2 Prenatal Cell-Free DNA Screening Upstream Analysis
8.3 Prenatal Cell-Free DNA Screening Midstream Analysis
8.4 Prenatal Cell-Free DNA Screening Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Prenatal Cell-Free DNA Screening Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Prenatal Cell-Free DNA Screening Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Prenatal Cell-Free DNA Screening Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Prenatal Cell-Free DNA Screening Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Prenatal Cell-Free DNA Screening Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Prenatal Cell-Free DNA Screening Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Prenatal Cell-Free DNA Screening Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Prenatal Cell-Free DNA Screening Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Prenatal Cell-Free DNA Screening Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Prenatal Cell-Free DNA Screening Players in 2022
Table 12. World Prenatal Cell-Free DNA Screening Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Prenatal Cell-Free DNA Screening Company Evaluation Quadrant
Table 14. Head Office of Key Prenatal Cell-Free DNA Screening Player
Table 15. Prenatal Cell-Free DNA Screening Market: Company Product Type Footprint
Table 16. Prenatal Cell-Free DNA Screening Market: Company Product Application Footprint
Table 17. Prenatal Cell-Free DNA Screening Mergers & Acquisitions Activity
Table 18. United States VS China Prenatal Cell-Free DNA Screening Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Prenatal Cell-Free DNA Screening Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Prenatal Cell-Free DNA Screening Companies, Headquarters (States, Country)
Table 21. United States Based Companies Prenatal Cell-Free DNA Screening Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Prenatal Cell-Free DNA Screening Revenue Market Share (2018-2023)
Table 23. China Based Prenatal Cell-Free DNA Screening Companies, Headquarters (Province, Country)
Table 24. China Based Companies Prenatal Cell-Free DNA Screening Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Prenatal Cell-Free DNA Screening Revenue Market Share (2018-2023)
Table 26. Rest of World Based Prenatal Cell-Free DNA Screening Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Prenatal Cell-Free DNA Screening Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Prenatal Cell-Free DNA Screening Revenue Market Share (2018-2023)
Table 29. World Prenatal Cell-Free DNA Screening Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Prenatal Cell-Free DNA Screening Market Size by Type (2018-2023) & (USD Million)
Table 31. World Prenatal Cell-Free DNA Screening Market Size by Type (2024-2029) & (USD Million)
Table 32. World Prenatal Cell-Free DNA Screening Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Prenatal Cell-Free DNA Screening Market Size by Application (2018-2023) & (USD Million)
Table 34. World Prenatal Cell-Free DNA Screening Market Size by Application (2024-2029) & (USD Million)
Table 35. Yourgene Health Basic Information, Area Served and Competitors
Table 36. Yourgene Health Major Business
Table 37. Yourgene Health Prenatal Cell-Free DNA Screening Product and Services
Table 38. Yourgene Health Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Yourgene Health Recent Developments/Updates
Table 40. Yourgene Health Competitive Strengths & Weaknesses
Table 41. Illumina Inc Basic Information, Area Served and Competitors
Table 42. Illumina Inc Major Business
Table 43. Illumina Inc Prenatal Cell-Free DNA Screening Product and Services
Table 44. Illumina Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Illumina Inc Recent Developments/Updates
Table 46. Illumina Inc Competitive Strengths & Weaknesses
Table 47. Agilent Technologies Inc Basic Information, Area Served and Competitors
Table 48. Agilent Technologies Inc Major Business
Table 49. Agilent Technologies Inc Prenatal Cell-Free DNA Screening Product and Services
Table 50. Agilent Technologies Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Agilent Technologies Inc Recent Developments/Updates
Table 52. Agilent Technologies Inc Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Inc Basic Information, Area Served and Competitors
Table 54. Thermo Fisher Scientific Inc Major Business
Table 55. Thermo Fisher Scientific Inc Prenatal Cell-Free DNA Screening Product and Services
Table 56. Thermo Fisher Scientific Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Thermo Fisher Scientific Inc Recent Developments/Updates
Table 58. Thermo Fisher Scientific Inc Competitive Strengths & Weaknesses
Table 59. Hoffmann-La Roche Ltd Basic Information, Area Served and Competitors
Table 60. Hoffmann-La Roche Ltd Major Business
Table 61. Hoffmann-La Roche Ltd Prenatal Cell-Free DNA Screening Product and Services
Table 62. Hoffmann-La Roche Ltd Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 64. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 65. Laboratory Corporation of America Holdings Basic Information, Area Served and Competitors
Table 66. Laboratory Corporation of America Holdings Major Business
Table 67. Laboratory Corporation of America Holdings Prenatal Cell-Free DNA Screening Product and Services
Table 68. Laboratory Corporation of America Holdings Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Laboratory Corporation of America Holdings Recent Developments/Updates
Table 70. Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
Table 71. GE Healthcare Basic Information, Area Served and Competitors
Table 72. GE Healthcare Major Business
Table 73. GE Healthcare Prenatal Cell-Free DNA Screening Product and Services
Table 74. GE Healthcare Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. GE Healthcare Recent Developments/Updates
Table 76. GE Healthcare Competitive Strengths & Weaknesses
Table 77. PerkinElmer Inc Basic Information, Area Served and Competitors
Table 78. PerkinElmer Inc Major Business
Table 79. PerkinElmer Inc Prenatal Cell-Free DNA Screening Product and Services
Table 80. PerkinElmer Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. PerkinElmer Inc Recent Developments/Updates
Table 82. PerkinElmer Inc Competitive Strengths & Weaknesses
Table 83. BGI Basic Information, Area Served and Competitors
Table 84. BGI Major Business
Table 85. BGI Prenatal Cell-Free DNA Screening Product and Services
Table 86. BGI Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. BGI Recent Developments/Updates
Table 88. Natera Inc Basic Information, Area Served and Competitors
Table 89. Natera Inc Major Business
Table 90. Natera Inc Prenatal Cell-Free DNA Screening Product and Services
Table 91. Natera Inc Prenatal Cell-Free DNA Screening Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 92. Global Key Players of Prenatal Cell-Free DNA Screening Upstream (Raw Materials)
Table 93. Prenatal Cell-Free DNA Screening Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Prenatal Cell-Free DNA Screening Picture
Figure 2. World Prenatal Cell-Free DNA Screening Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Prenatal Cell-Free DNA Screening Total Market Size (2018-2029) & (USD Million)
Figure 4. World Prenatal Cell-Free DNA Screening Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Prenatal Cell-Free DNA Screening Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Prenatal Cell-Free DNA Screening Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Prenatal Cell-Free DNA Screening Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Prenatal Cell-Free DNA Screening Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Prenatal Cell-Free DNA Screening Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Prenatal Cell-Free DNA Screening Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Prenatal Cell-Free DNA Screening Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Prenatal Cell-Free DNA Screening Revenue (2018-2029) & (USD Million)
Figure 13. Prenatal Cell-Free DNA Screening Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Prenatal Cell-Free DNA Screening Consumption Value (2018-2029) & (USD Million)
Figure 16. World Prenatal Cell-Free DNA Screening Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Prenatal Cell-Free DNA Screening Consumption Value (2018-2029) & (USD Million)
Figure 18. China Prenatal Cell-Free DNA Screening Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Prenatal Cell-Free DNA Screening Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Prenatal Cell-Free DNA Screening Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Prenatal Cell-Free DNA Screening Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Prenatal Cell-Free DNA Screening Consumption Value (2018-2029) & (USD Million)
Figure 23. India Prenatal Cell-Free DNA Screening Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Prenatal Cell-Free DNA Screening by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Prenatal Cell-Free DNA Screening Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Prenatal Cell-Free DNA Screening Markets in 2022
Figure 27. United States VS China: Prenatal Cell-Free DNA Screening Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Prenatal Cell-Free DNA Screening Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Prenatal Cell-Free DNA Screening Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Prenatal Cell-Free DNA Screening Market Size Market Share by Type in 2022
Figure 31. Combined First Trimester Screening
Figure 32. Second Trimester Maternal Serum Screening
Figure 33. World Prenatal Cell-Free DNA Screening Market Size Market Share by Type (2018-2029)
Figure 34. World Prenatal Cell-Free DNA Screening Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Prenatal Cell-Free DNA Screening Market Size Market Share by Application in 2022
Figure 36. Diagnostic Laboratories
Figure 37. Hospitals
Figure 38. Prenatal Cell-Free DNA Screening Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source